Pioneer Hi Bred International issued US patent for 'maize hybrid X95C442'

ALEXANDRIA, Virginia , March 19, 2014 () – United States Patent no. 8,674,173, issued on March 18, was assigned to Pioneer Hi Bred International Inc (Johnston, Iowa).

"Maize hybrid X95C442" was invented by Edwin Michael Grote (Milton, Wis.), Todd Elliott Piper (Mankato, Minn.), Jay Robert Hotchkiss (Brookings, S.D.), Julie Ho (Davis, Calif.), Thomas Craig Kevern (Milton, Wis.), Michael Adam Chandler (Stoughton, Wis.), Julia Xiuling Zhang (Mankato, Minn.), David B. Fischer (Robins, Iowa), Dean William Christensen (Northfield, Minn.) and Michael Joseph O'Leary (Eau Claire, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel maize variety designated X95C442 and seed, plants and plant parts thereof, produced by crossing Pioneer Hi-Bred International, Inc. proprietary inbred maize varieties. Methods for producing a maize plant that comprises crossing hybrid maize variety X95C442 with another maize plant. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X95C442 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby. This invention relates to the maize variety X95C442, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X95C442. This invention further relates to methods for producing maize varieties derived from maize variety X95C442."

The patent was filed on Feb. 15, 2012, under Application No. 13/396,790.

*For further information, including images, charts and tables, please visit:

For any query with respect to this article or any other content requirement, please contact Editor at

(c) 2014 US Fed News (HT Syndication)

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.